Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 55

1.

Activation of the interleukin-34 inflammatory pathway in response to influenza A virus infection.

Yu G, Bing Y, Zhu S, Li W, Xia L, Li Y, Liu Z.

Am J Med Sci. 2015 Feb;349(2):145-50. doi: 10.1097/MAJ.0000000000000373.

PMID:
25415279
2.

Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection.

Li W, Liu Y, Mukhtar MM, Gong R, Pan Y, Rasool ST, Gao Y, Kang L, Hao Q, Peng G, Chen Y, Chen X, Wu J, Zhu Y.

PLoS One. 2008 Apr 16;3(4):e1985. doi: 10.1371/journal.pone.0001985.

3.

Negative feedback regulation of IL-32 production by iNOS activation in response to dsRNA or influenza virus infection.

Li W, Yang F, Liu Y, Gong R, Liu L, Feng Y, Hu P, Sun W, Hao Q, Kang L, Wu J, Zhu Y.

Eur J Immunol. 2009 Apr;39(4):1019-24. doi: 10.1002/eji.200838885.

4.

Influenza A virus inhibits influenza virus replication by inducing IL-37.

Zhou F, Zhu CL, Niu ZL, Xu FX, Song H, Liu XH.

J Clin Lab Anal. 2019 Jan;33(1):e22638. doi: 10.1002/jcla.22638. Epub 2018 Aug 11.

PMID:
30098064
5.

Soluble interleukin-6 receptor is elevated during influenza A virus infection and mediates the IL-6 and IL-32 inflammatory cytokine burst.

Wang J, Wang Q, Han T, Li YK, Zhu SL, Ao F, Feng J, Jing MZ, Wang L, Ye LB, Zhu Y.

Cell Mol Immunol. 2015 Sep;12(5):633-44. doi: 10.1038/cmi.2014.80. Epub 2014 Sep 1.

6.

Gene Expression and Antiviral Activity of Interleukin-35 in Response to Influenza A Virus Infection.

Wang L, Zhu S, Xu G, Feng J, Han T, Zhao F, She YL, Liu S, Ye L, Zhu Y.

J Biol Chem. 2016 Aug 5;291(32):16863-76. doi: 10.1074/jbc.M115.693101. Epub 2016 Jun 15.

7.

Th1 and Th17 responses to Helicobacter pylori in Bangladeshi infants, children and adults.

Bhuiyan TR, Islam MM, Uddin T, Chowdhury MI, Janzon A, Adamsson J, Lundin SB, Qadri F, Lundgren A.

PLoS One. 2014 Apr 8;9(4):e93943. doi: 10.1371/journal.pone.0093943. eCollection 2014.

8.

Decreased IL-27 expression in association with an increased Th17 response in Vogt-Koyanagi-Harada disease.

Wang C, Tian Y, Lei B, Xiao X, Ye Z, Li F, Kijlstra A, Yang P.

Invest Ophthalmol Vis Sci. 2012 Jul 10;53(8):4668-75. doi: 10.1167/iovs.12-9863.

PMID:
22669715
9.

Interleukin-21 modulates Th1 and Th17 responses in giant cell arteritis.

Terrier B, Geri G, Chaara W, Allenbach Y, Rosenzwajg M, Costedoat-Chalumeau N, Fouret P, Musset L, Benveniste O, Six A, Klatzmann D, Saadoun D, Cacoub P.

Arthritis Rheum. 2012 Jun;64(6):2001-11. doi: 10.1002/art.34327. Epub 2011 Dec 6.

10.

Infection with influenza virus induces IL-33 in murine lungs.

Le Goffic R, Arshad MI, Rauch M, L'Helgoualc'h A, Delmas B, Piquet-Pellorce C, Samson M.

Am J Respir Cell Mol Biol. 2011 Dec;45(6):1125-32. doi: 10.1165/rcmb.2010-0516OC. Epub 2011 Jun 3.

PMID:
21642589
11.

The allogeneic umbilical cord mesenchymal stem cells regulate the function of T helper 17 cells from patients with rheumatoid arthritis in an in vitro co-culture system.

Wang Q, Li X, Luo J, Zhang L, Ma L, Lv Z, Xue L.

BMC Musculoskelet Disord. 2012 Dec 13;13:249. doi: 10.1186/1471-2474-13-249.

12.

IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection.

Li W, Sun W, Liu L, Yang F, Li Y, Chen Y, Fang J, Zhang W, Wu J, Zhu Y.

J Immunol. 2010 Nov 1;185(9):5056-65. doi: 10.4049/jimmunol.0902667. Epub 2010 Oct 1.

13.

Increased Th17 cells and interleukin-17 contribute to immune activation and disease aggravation in patients with chronic hepatitis B virus infection.

Yang B, Wang Y, Zhao C, Yan W, Che H, Shen C, Zhao M.

Immunol Lett. 2013 Jan;149(1-2):41-9. doi: 10.1016/j.imlet.2012.12.001. Epub 2012 Dec 10.

PMID:
23237940
14.

Decreased interleukin 27 expression is associated with active uveitis in Behçet's disease.

Wang C, Tian Y, Ye Z, Kijlstra A, Zhou Y, Yang P.

Arthritis Res Ther. 2014 May 28;16(3):R117. doi: 10.1186/ar4570.

15.

Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages.

Paget C, Ivanov S, Fontaine J, Renneson J, Blanc F, Pichavant M, Dumoutier L, Ryffel B, Renauld JC, Gosset P, Gosset P, Si-Tahar M, Faveeuw C, Trottein F.

J Biol Chem. 2012 Mar 16;287(12):8816-29. doi: 10.1074/jbc.M111.304758. Epub 2012 Jan 31.

16.

Neutralizations of IL-17A and IL-21 regulate regulatory T cell/T-helper 17 imbalance via T-helper 17-associated signaling pathway in immune thrombocytopenia.

Hu Y, Wang X, Yu S, Hou Y, Ma D, Hou M.

Expert Opin Ther Targets. 2015 Jun;19(6):723-32. doi: 10.1517/14728222.2015.1016499.

PMID:
25976230
17.

Psoriasis and other Th17-mediated skin diseases.

Tokura Y, Mori T, Hino R.

J UOEH. 2010 Dec 1;32(4):317-28. Review.

PMID:
21226422
18.

Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: contribution to the chronicity of rheumatoid arthritis.

Eljaafari A, Tartelin ML, Aissaoui H, Chevrel G, Osta B, Lavocat F, Miossec P.

Arthritis Rheum. 2012 Jul;64(7):2147-57. doi: 10.1002/art.34391.

19.

Serum levels of Th17 associated cytokines in chronic hepatitis C virus infection.

Sousa GM, Oliveira IS, Andrade LJ, Sousa-Atta ML, Paraná R, Atta AM.

Cytokine. 2012 Oct;60(1):138-42. doi: 10.1016/j.cyto.2012.06.003. Epub 2012 Jun 27.

20.

Activation of c-jun N-terminal kinase upon influenza A virus (IAV) infection is independent of pathogen-related receptors but dependent on amino acid sequence variations of IAV NS1.

Nacken W, Anhlan D, Hrincius ER, Mostafa A, Wolff T, Sadewasser A, Pleschka S, Ehrhardt C, Ludwig S.

J Virol. 2014 Aug;88(16):8843-52. doi: 10.1128/JVI.00424-14. Epub 2014 May 28.

Supplemental Content

Support Center